COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
Dilek Yilmaz CiftdoganYıldız Ekemen-KeleşBenhur Sirvan CetinNazan Dalgic KarabulutMelike EmirogluZafer BagciAyse BuyukcamEmine Hafize ErdenizGul ArgaEdanur YesilOzlem CakiciAdem KarbuzZumrut Sahbudak BalSoner Sertan KaraArife OzerOzge Metin AkcanSefika Elmas BozdemirAyse Berna AnilHatice UygunOmer KilicSelda Hancerli TorunZuhal UmitMurat SutcuBerfin Ozgokce OzmenHatice Karaoglu AsrakGulsum AlkanAhu Kara AksayCuneyt UgurAhmet Ziya BirbilenBurcu Bursal DuramazEsra Akyuz OzkanOzgur BurakaySema Yildirim ArslanEda Karadag OncelSerkan Fazli CelikAhmet Osman KilicSeval OzenRemzi SarikayaDemet DemirkolGazi ArslanOzden TurelAhmet SertErgul SariZerrin OrbakIrfan Oguz SahinCelal VaranHacer AkturkSadiye Kubra Tuter OzFatih DurakMehmet Burhan OflazManolya KaraDerya KarpuzMey Talip PetmezciNevin HatipogluSelim OncelMehmet TurgutFerhan ElmaliAyper SomerNecdet KuyucuEner Cagri DinleyiciZafer KurugölErgin CiftciAtes KaraPublished in: European journal of pediatrics (2022)
• Half of the patients had clinical features that overlapped with Kawasaki disease. • In patients whose clinical features overlapped with KD, procalcitonin levels were almost 15 times higher than normal. • Lethargy increased the risk of overlap with KD by 2.6-fold in MIS-C patients. • Transient bradycardia was noted in approximately 10% of our patients after initiation of treatment.